PDUFA V: What you need to know about the upcoming Prescription Drug User Fee Act
Rho
All news > Videos
Patheon launches CMC consultancy in face of restructuring plans
  |
Geoff GlassExecutive VP of global sales and marketing - PatheonPatheon has launched a new consulting service designed to give emerging biotechs and pharmas a boost in their drug development efforts. Published: 15-May-2012 |
Parexel discusses transdermal drug delivery techs
 |
Ravi HarapanhalliPrincipal Consultant and Practice Lead for Late Stage Product Development Parexel Consulting - ParexelElectroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli. Published: 22-Dec-2011 |
Quotient says screening of prototype formulations is crucial to drug delivery
 |
Peter ScholeVP, pharmaceutical sciences - Quotient ClinicalQuotient has stressed the importance of screening prototype formulations early in the development process to ensure efficient drug delivery in later phases. Published: 13-Dec-2011 |
Covance adding mass spec for biosimilars
 |
Ray KaiserChief Scientific Officer, Biotechnology - CovanceCovance is adding mass spectrometry and other capabilities to meet growing demand for biosimilar comparability services. Published: 23-Nov-2011 |
Patheon mulls drug delivery tech deals to accelerate development services growth
 |
Mark KontnyPresident, Global Pharmaceutical Development Services - PatheonPatheon is considering buying unique drug delivery technologies to expand its development service capabilities. Published: 14-Nov-2011 |
Catalent eyes acquisitions in emerging market and drug delivery expansion
 |
Scott HoultonPresident, Development and Clinical Services - CatalentCatalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets. Published: 07-Nov-2011 |
Icon sets its sights on genomics development
 |
Brian O’Dwyersenior VP for global bioanalytical services - IconIcon will this year focus its R&D efforts on gaining new grounds in genomics, said Brian O’Dwyer.Icon Published: 31-Oct-2011 |
Norwich amps up its pilot scale production capabilities at NY plant
 |
Terry NovakPresident - Norwich PharmaceuticalsNorwich Pharmaceuticals has expanded its pilot scale production capabilities at its CDMO plant in New York, US. Published: 27-Oct-2011 |
Novozymes reveals the key to its supply chain management strategy
 |
Luke Dimasimarketing manager - NovozymesNovozymes has achieved a successful supply chain and risk mitigation strategy through implementing its own policy with chemicals company SAFC, says Luke Dimasi. Published: 26-Sep-2011 |
New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier
 |
Gilles CottierPresident - SAFCSAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week. Published: 19-Sep-2011 |
Rapid recruitment in emerging regions can overload sites; FDA
 |
Cynthia KleppingerMedical Officer, Division of Scientific Investigations - CDER, FDAThe US FDA has warned that rapid patient enrolment in emerging markets can overload sites that lack the staff to oversee data as it is generated. Published: 18-Aug-2011 |
Apps turn iPads & iPods into consent & compliance tools
 |
Jay UdaniCEO - Medicus ResearchSystemedicus has developed informed consent and patient compliance apps for iPads and iPods and is looking to license the tools to CROs and sponsors. Published: 08-Aug-2011 |
Sponsors and CROs both have key role in quality; FDA
 |
Ann Meeker O’ConnellActing Associate Director of Risk Science, Intelligence & Prioritization - FDAThe FDA is emphasising the key role both sponsors and CROs play in ensuring high quality clinical trials. Published: 03-Aug-2011 |
ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011
 |
The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011. Published: 02-Aug-2011 |
OSP meets Pfizer's REMOTE virtual trial partners at DIA 2011
 |
In June global drug giant Pfizer began what it described as the world’s first ‘virtual trial’ using mobile technology to collect data from patients in their own homes rather than at research sites. Published: 27-Jul-2011 |
Quintiles talks about challenges of data management in today’s trials sector
 |
Paula Brown StaffordPresident, Clinical Development - QuintilesUS CRO Quintiles says that demand for rapid access to clinical trial data is driving the development of vendor neutral management systems. Published: 13-Jul-2011 |
Fiscal benefits of drugs a priority for cash-strapped countries
 |
Geoff Fatzingerdirector of regulatory affairs and strategic product development - INC ResearchCash-strapped countries are making biopharm consider a product’s fiscal benefits earlier in development, according to INC. Published: 12-Jul-2011 |
Strategic relationships are changing Pharma and CRO skillset says Parexel
 |
Joshua Schultzcorporate VP of strategic account leadership - ParexelParexel says strategic partnerships let pharmaceutical companies streamline how they work with contractors and are changing how CROs view outcomes. Published: 07-Jul-2011 |
Synteract talks rescue studies at DIA 2011
 |
Stewart BielerCOO - SynteractSynteract says the use of non-validated data systems in clinical trials is a key driver for the ‘rescue study’ segment of the contract research sector. Published: 06-Jul-2011 |
Theorem CR talks about life after spin out at DIA 2011
 |
James PuseyCEO - Theorem Clinical ResearchRebranded CRO Theorem Clinical Research talks about life as an independent organisation and the current vogue for private equity investments. Published: 05-Jul-2011 |
Parexel talks global trial regulations at DIA 2011
 |
Alberto GrignoloCorporate Vice President, Global Strategy and Services - Parexel InternationalUS CRO Parexel says the pharmaceutical industry’s desire to access international markets is the key challenge facing regulatory experts in the contract research sector. Published: 04-Jul-2011 |
Chiltern says strategic deals are good for the CRO sector
 |
Aize SminkSenior Executive VP, Global Clinical Development - ChilternChiltern says that strategic partnering in the contract research sector enables CROs to plan for the longer term and is having a tangible impact on brining drugs to market. Published: 30-Jun-2011 |
Quintiles launches silo busting data management platform at DIA
 |
Thomas GrundstromVP of global data solutions - QuintilesCRO Quintiles chose DIA 2011 to launch its new Infosario clinical trial data and information management system which, it says, will ‘bust’ the information silos that hamper the research process. Published: 29-Jun-2011 |
Celerion talks about research sector in South America
 |
US CRO Celerion gained Brazilian National Health Surveillance Agency (Agência Nacional de Vigilancia Sanitaria ANVISA) approval for its bioanalysis labs in Lincoln, Nebraska and in Belfast, Northern Ireland. Published: 28-Jun-2011 |
PRA reflects on data and information management at DIA
 |
Steve PowellSenior VP of clinical informatics and late phase services - PRA InternationalPRA International says that the adoption of new industry standards is changing how the research sector approaches data and information management and is creating opportunities for the use of innovative technologies. Published: 27-Jun-2011 |
Supplier Webinars
Technical Papers
- Effective Controlled Substances Supply Chain Management
DPT Labs - Clinical Trial Logistics in Africa: Ensuring Quality, Compliance and Control within the Pharmaceutical Supply Chain
World Courier - The new product development reality
Parexel - Implementing LEAN Techniques in Quality Control
Baxter - A Clinical Perspective on IV Medication Delivery
Baxter - SGS-Clinical-Influenza Clinical Trials…
SGS - Sample Prep Proposed USP<233> Elemental Impurities
SGS - Risk-Reducing Solutions for Global Study Logistics
World Courier